Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types.

Mathios D, Hwang T, Xia Y, Phallen J, Rui Y, See AP, Maxwell R, Belcaid Z, Casaos J, Burger PC, McDonald KL, Gallia GL, Cope L, Kai M, Brem H, Pardoll DM, Ha P, Green JJ, Velculescu VE, Bettegowda C, Park CK, Lim M.

Int J Cancer. 2019 Dec 15;145(12):3425-3435. doi: 10.1002/ijc.32587. Epub 2019 Aug 9.

PMID:
31373686
2.

Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma.

Hwang T, Mathios D, McDonald KL, Daris I, Park SH, Burger PC, Kim S, Dho YS, Carolyn H, Bettegowda C, Shin JH, Lim M, Park CK.

Acta Neuropathol Commun. 2019 Jun 3;7(1):88. doi: 10.1186/s40478-019-0744-0. Erratum in: Acta Neuropathol Commun. 2019 Aug 14;7(1):131.

3.

Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.

Wu A, Maxwell R, Xia Y, Cardarelli P, Oyasu M, Belcaid Z, Kim E, Hung A, Luksik AS, Garzon-Muvdi T, Jackson CM, Mathios D, Theodros D, Cogswell J, Brem H, Pardoll DM, Lim M.

J Neurooncol. 2019 Jun;143(2):241-249. doi: 10.1007/s11060-019-03172-5. Epub 2019 Apr 25.

PMID:
31025274
4.

Why is immunotherapy for glioblastoma "Lag"-ging.

Mathios D, Lim M.

Oncotarget. 2019 Feb 8;10(12):1228-1229. doi: 10.18632/oncotarget.26648. eCollection 2019 Feb 8. No abstract available.

5.

Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system.

Maxwell R, Luksik AS, Garzon-Muvdi T, Hung AL, Kim ES, Wu A, Xia Y, Belcaid Z, Gorelick N, Choi J, Theodros D, Jackson CM, Mathios D, Ye X, Tran PT, Redmond KJ, Brem H, Pardoll DM, Kleinberg LR, Lim M.

Oncoimmunology. 2018 Sep 6;7(12):e1500108. doi: 10.1080/2162402X.2018.1500108. eCollection 2018.

6.

Treatment-refractory Escherichia coli subdural empyema caused by infection of a chronic subdural hematoma in an infant.

Chen JA, Mathios D, Hidalgo J, Cohen AR.

Childs Nerv Syst. 2019 Apr;35(4):719-723. doi: 10.1007/s00381-018-4003-7. Epub 2018 Nov 16.

PMID:
30446813
7.

Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma.

Harris-Bookman S, Mathios D, Martin AM, Xia Y, Kim E, Xu H, Belcaid Z, Polanczyk M, Barberi T, Theodros D, Kim J, Taube JM, Burger PC, Selby M, Taitt C, Korman A, Ye X, Drake CG, Brem H, Pardoll DM, Lim M.

Int J Cancer. 2018 Dec 15;143(12):3201-3208. doi: 10.1002/ijc.31661. Epub 2018 Sep 24.

PMID:
30248181
8.

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.

Hung AL, Maxwell R, Theodros D, Belcaid Z, Mathios D, Luksik AS, Kim E, Wu A, Xia Y, Garzon-Muvdi T, Jackson C, Ye X, Tyler B, Selby M, Korman A, Barnhart B, Park SM, Youn JI, Chowdhury T, Park CK, Brem H, Pardoll DM, Lim M.

Oncoimmunology. 2018 May 24;7(8):e1466769. doi: 10.1080/2162402X.2018.1466769. eCollection 2018.

9.

Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic.

Stone ML, Chiappinelli KB, Li H, Murphy LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, Hung CF, Bhargava V, Wiehagen KR, Cowley GS, Bachman KE, Strick R, Strissel PL, Baylin SB, Zahnow CA.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8583-E8584. doi: 10.1073/pnas.1811015115. Epub 2018 Sep 4. No abstract available.

10.

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

Stone ML, Chiappinelli KB, Li H, Murphy LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, Hung CF, Bhargava V, Wiehagen KR, Cowley GS, Bachman KE, Strick R, Strissel PL, Baylin SB, Zahnow CA.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10981-E10990. doi: 10.1073/pnas.1712514114. Epub 2017 Dec 4.

11.

Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.

Mathios D, Kim JE, Mangraviti A, Phallen J, Park CK, Jackson CM, Garzon-Muvdi T, Kim E, Theodros D, Polanczyk M, Martin AM, Suk I, Ye X, Tyler B, Bettegowda C, Brem H, Pardoll DM, Lim M.

Sci Transl Med. 2016 Dec 21;8(370):370ra180. doi: 10.1126/scitranslmed.aag2942.

12.

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M.

J Immunother Cancer. 2016 Nov 4;4:74. doi: 10.1186/s40425-016-0181-6. eCollection 2016.

13.

Efficacy of primary microvascular decompression versus subsequent microvascular decompression for trigeminal neuralgia.

Theodros D, Rory Goodwin C, Bender MT, Zhou X, Garzon-Muvdi T, De la Garza-Ramos R, Abu-Bonsrah N, Mathios D, Blitz AM, Olivi A, Carson B, Bettegowda C, Lim M.

J Neurosurg. 2017 May;126(5):1691-1697. doi: 10.3171/2016.5.JNS151692. Epub 2016 Jul 15.

PMID:
27419826
14.

Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas.

Kim JE, Patel MA, Mangraviti A, Kim ES, Theodros D, Velarde E, Liu A, Sankey EW, Tam A, Xu H, Mathios D, Jackson CM, Harris-Bookman S, Garzon-Muvdi T, Sheu M, Martin AM, Tyler BM, Tran PT, Ye X, Olivi A, Taube JM, Burger PC, Drake CG, Brem H, Pardoll DM, Lim M.

Clin Cancer Res. 2017 Jan 1;23(1):124-136. doi: 10.1158/1078-0432.CCR-15-1535. Epub 2016 Jun 29.

15.

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M.

J Immunother Cancer. 2016 May 17;4:28. doi: 10.1186/s40425-016-0132-2. eCollection 2016. Erratum in: J Immunother Cancer. 2016 Nov 4;4:74.

16.

Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

Mathios D, Ruzevick J, Jackson CM, Xu H, Shah SR, Taube JM, Burger PC, McCarthy EF, Quinones-Hinojosa A, Pardoll DM, Lim M.

J Neurooncol. 2016 May;128(1):183. doi: 10.1007/s11060-016-2130-0. No abstract available.

PMID:
27161248
17.

Reduced CSF leak in complete calvarial reconstructions of microvascular decompression craniectomies using calcium phosphate cement.

Eseonu CI, Goodwin CR, Zhou X, Theodros D, Bender MT, Mathios D, Bettegowda C, Lim M.

J Neurosurg. 2015 Dec;123(6):1476-9. doi: 10.3171/2015.1.JNS142102. Epub 2015 Jul 31.

18.

Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.

Mathios D, Park CK, Marcus WD, Alter S, Rhode PR, Jeng EK, Wong HC, Pardoll DM, Lim M.

Int J Cancer. 2016 Jan 1;138(1):187-94. doi: 10.1002/ijc.29686. Epub 2015 Jul 28.

19.

PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

Mathios D, Ruzevick J, Jackson CM, Xu H, Shah SR, Taube JM, Burger PC, McCarthy EF, Quinones-Hinojosa A, Pardoll DM, Lim M.

J Neurooncol. 2015 Jan;121(2):251-9. doi: 10.1007/s11060-014-1637-5. Epub 2014 Oct 28. Erratum in: J Neurooncol. 2016 May;128(1):183.

20.

Long-term patient outcomes after posterior cervical foraminotomy: an analysis of 151 cases.

Bydon M, Mathios D, Macki M, de la Garza-Ramos R, Sciubba DM, Witham TF, Wolinsky JP, Gokaslan ZL, Bydon A.

J Neurosurg Spine. 2014 Nov;21(5):727-31. doi: 10.3171/2014.7.SPINE131110. Epub 2014 Aug 15.

PMID:
25127430
21.

Accuracy of C2 pedicle screw placement using the anatomic freehand technique.

Bydon M, Mathios D, Macki M, De la Garza-Ramos R, Aygun N, Sciubba DM, Witham TF, Gokaslan ZL, Bydon A, Wolinksy JP.

Clin Neurol Neurosurg. 2014 Oct;125:24-7. doi: 10.1016/j.clineuro.2014.07.017. Epub 2014 Jul 20.

PMID:
25080046
22.

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.

Belcaid Z, Phallen JA, Zeng J, See AP, Mathios D, Gottschalk C, Nicholas S, Kellett M, Ruzevick J, Jackson C, Albesiano E, Durham NM, Ye X, Tran PT, Tyler B, Wong JW, Brem H, Pardoll DM, Drake CG, Lim M.

PLoS One. 2014 Jul 11;9(7):e101764. doi: 10.1371/journal.pone.0101764. eCollection 2014.

23.

A novel method of anterior lumbosacral cage reconstruction.

Mathios D, Kaloostian PE, Bydon A, Sciubba DM, Wolinsky JP, Gokaslan ZL, Witham TF.

J Neurosurg Spine. 2014 Feb;20(2):204-8. doi: 10.3171/2013.11.SPINE13518. Epub 2013 Dec 6.

PMID:
24313677
24.

α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.

Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, Lechpammer M, Archer TC, Tran P, Reimer RJ, Cook JM, Lim M, Jensen FE, Pomeroy SL, Cho YJ.

Acta Neuropathol. 2014 Apr;127(4):593-603. doi: 10.1007/s00401-013-1205-7. Epub 2013 Nov 7.

25.

Multiple primary intramedullary ependymomas: a case report and review of the literature.

Bydon M, Mathios D, Aguayo-Alvarez JJ, Ho C, Gokaslan ZL, Bydon A.

Spine J. 2013 Oct;13(10):1379-86. doi: 10.1016/j.spinee.2013.06.037. Epub 2013 Aug 27. Review.

PMID:
23988460
26.

Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors.

Nicholas S, Mathios D, Ruzevick J, Jackson C, Yang I, Lim M.

Brain Tumor Res Treat. 2013 Apr;1(1):2-8. doi: 10.14791/btrt.2013.1.1.2. Epub 2013 Apr 30. Review.

27.

The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009).

Stranjalis G, Kalamatianos T, Stavrinou LC, Mathios D, Koutsarnakis C, Tzavara C, Loufardaki M, Protopappa D, Argyrakos T, Rontogianni DP, Sakas DE.

Surg Neurol Int. 2013;4:23. doi: 10.4103/2152-7806.107893. Epub 2013 Feb 27.

28.

Metastatic melanoma to the brain: surgery and radiation is still the standard of care.

Nicholas S, Mathios D, Jackson C, Lim M.

Curr Treat Options Oncol. 2013 Jun;14(2):264-79. doi: 10.1007/s11864-013-0228-6.

PMID:
23504304
29.

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.

Zeng J, See AP, Phallen J, Jackson CM, Belcaid Z, Ruzevick J, Durham N, Meyer C, Harris TJ, Albesiano E, Pradilla G, Ford E, Wong J, Hammers HJ, Mathios D, Tyler B, Brem H, Tran PT, Pardoll D, Drake CG, Lim M.

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):343-9. doi: 10.1016/j.ijrobp.2012.12.025. Epub 2013 Feb 22.

Supplemental Content

Loading ...
Support Center